These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29932770)

  • 1. Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase.
    Parajuli N; Takahara S; Matsumura N; Kim TT; Ferdaoussi M; Migglautsch AK; Zechner R; Breinbauer R; Kershaw EE; Dyck JRB
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H879-H884. PubMed ID: 29932770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.
    Takahara S; Ferdaoussi M; Srnic N; Maayah ZH; Soni S; Migglautsch AK; Breinbauer R; Kershaw EE; Dyck JRB
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H432-H446. PubMed ID: 33185110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors.
    Jin J; Huang S; Wang L; Leng Y; Lu W
    Chem Biol Drug Des; 2017 Dec; 90(6):1122-1133. PubMed ID: 28548386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage.
    Thiele A; Luettges K; Ritter D; Beyhoff N; Smeir E; Grune J; Steinhoff JS; Schupp M; Klopfleisch R; Rothe M; Wilck N; Bartolomaeus H; Migglautsch AK; Breinbauer R; Kershaw EE; Grabner GF; Zechner R; Kintscher U; Foryst-Ludwig A
    Cardiovasc Res; 2022 Aug; 118(11):2488-2505. PubMed ID: 34061169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Atglistatin closely related analogues: Synthesis and structure-activity relationship towards adipose triglyceride lipase inhibition.
    Roy PP; D'Souza K; Cuperlovic-Culf M; Kienesberger PC; Touaibia M
    Eur J Med Chem; 2016 Aug; 118():290-8. PubMed ID: 27155760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction.
    Bottermann K; Granade ME; Oenarto V; Fischer JW; Harris TE
    J Cardiovasc Pharmacol Ther; 2021 May; 26(3):289-297. PubMed ID: 33150796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose Triglyceride Lipase-Mediated Adipocyte Lipolysis Exacerbates Acute Pancreatitis Severity in Mouse Models and Patients.
    Xie X; Liu Y; Yang Q; Ma X; Lu Y; Hu Y; Zhang G; Ke L; Tong Z; Liu Y; Xue J; Lu G; Li W
    Am J Pathol; 2024 Aug; 194(8):1494-1510. PubMed ID: 38705384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL).
    Mayer N; Schweiger M; Fuchs E; Migglautsch AK; Doler C; Grabner GF; Romauch M; Melcher MC; Zechner R; Zimmermann R; Breinbauer R
    Bioorg Med Chem; 2020 Aug; 28(16):115610. PubMed ID: 32690265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of small-molecule inhibitors targeting adipose triglyceride lipase.
    Mayer N; Schweiger M; Romauch M; Grabner GF; Eichmann TO; Fuchs E; Ivkovic J; Heier C; Mrak I; Lass A; Höfler G; Fledelius C; Zechner R; Zimmermann R; Breinbauer R
    Nat Chem Biol; 2013 Dec; 9(12):785-7. PubMed ID: 24096302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reduction of lipid-sourced energy production caused by ATGL inhibition cannot be compensated by activation of HSL, autophagy, and utilization of other nutrients in fish.
    Han SL; Liu Y; Limbu SM; Chen LQ; Zhang ML; Du ZY
    Fish Physiol Biochem; 2021 Feb; 47(1):173-188. PubMed ID: 33245450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice.
    Schweiger M; Romauch M; Schreiber R; Grabner GF; Hütter S; Kotzbeck P; Benedikt P; Eichmann TO; Yamada S; Knittelfelder O; Diwoky C; Doler C; Mayer N; De Cecco W; Breinbauer R; Zimmermann R; Zechner R
    Nat Commun; 2017 Mar; 8():14859. PubMed ID: 28327588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose triglyceride lipase deletion from adipocytes, but not skeletal myocytes, impairs acute exercise performance in mice.
    Dubé JJ; Sitnick MT; Schoiswohl G; Wills RC; Basantani MK; Cai L; Pulinilkunnil T; Kershaw EE
    Am J Physiol Endocrinol Metab; 2015 May; 308(10):E879-90. PubMed ID: 25783895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced ATGL-mediated lipolysis attenuates β-adrenergic-induced AMPK signaling, but not the induction of PKA-targeted genes, in adipocytes and adipose tissue.
    MacPherson RE; Dragos SM; Ramos S; Sutton C; Frendo-Cumbo S; Castellani L; Watt MJ; Perry CG; Mutch DM; Wright DC
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C269-76. PubMed ID: 27357546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes.
    Grahn THM; Kaur R; Yin J; Schweiger M; Sharma VM; Lee MJ; Ido Y; Smas CM; Zechner R; Lass A; Puri V
    J Biol Chem; 2014 Apr; 289(17):12029-12039. PubMed ID: 24627478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic triglyceride lipase mediates lipotoxic systemic inflammation.
    de Oliveira C; Khatua B; Noel P; Kostenko S; Bag A; Balakrishnan B; Patel KS; Guerra AA; Martinez MN; Trivedi S; McCullough A; Lam-Himlin DM; Navina S; Faigel DO; Fukami N; Pannala R; Phillips AE; Papachristou GI; Kershaw EE; Lowe ME; Singh VP
    J Clin Invest; 2020 Apr; 130(4):1931-1947. PubMed ID: 31917686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
    Salatzki J; Foryst-Ludwig A; Bentele K; Blumrich A; Smeir E; Ban Z; Brix S; Grune J; Beyhoff N; Klopfleisch R; Dunst S; Surma MA; Klose C; Rothe M; Heinzel FR; Krannich A; Kershaw EE; Beule D; Schulze PC; Marx N; Kintscher U
    PLoS Genet; 2018 Jan; 14(1):e1007171. PubMed ID: 29320510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice.
    Schoiswohl G; Stefanovic-Racic M; Menke MN; Wills RC; Surlow BA; Basantani MK; Sitnick MT; Cai L; Yazbeck CF; Stolz DB; Pulinilkunnil T; O'Doherty RM; Kershaw EE
    Endocrinology; 2015 Oct; 156(10):3610-24. PubMed ID: 26196542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adipose triglyceride lipase in lipid and glucose homeostasis: lessons from transgenic mice.
    Trites MJ; Clugston RD
    Lipids Health Dis; 2019 Nov; 18(1):204. PubMed ID: 31757217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual regulation of adipose triglyceride lipase by pigment epithelium-derived factor: a novel mechanistic insight into progressive obesity.
    Dai Z; Qi W; Li C; Lu J; Mao Y; Yao Y; Li L; Zhang T; Hong H; Li S; Zhou T; Yang Z; Yang X; Gao G; Cai W
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):123-34. PubMed ID: 23850519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derived from G0/G1 switch gene 2 acts as noncompetitive inhibitor of adipose triglyceride lipase.
    Cerk IK; Salzburger B; Boeszoermenyi A; Heier C; Pillip C; Romauch M; Schweiger M; Cornaciu I; Lass A; Zimmermann R; Zechner R; Oberer M
    J Biol Chem; 2014 Nov; 289(47):32559-70. PubMed ID: 25258314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.